First Command Advisory Services, Inc. Neurocrine Biosciences Inc Transaction History
First Command Advisory Services, Inc.
- $10.3 Billion
- Q1 2025
A detailed history of First Command Advisory Services, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Command Advisory Services, Inc. holds 13 shares of NBIX stock, worth $1,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$1,399% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
647Shares Held
95.3MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.53 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$527 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$325 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$273 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...